As the most common infection among sick patients in intensive care units, OHSU will begin its clinical trial to test if a specialized breathing tube can reduce the risk of pneumonia in emergency intubation situations.

OHSU is the only hospital in Oregon that repairs, replaces all heart valves without open-heart surgery.

By acquiring OHSU's MolecularMD, the clinical research organization ICON, based in Dublin, Ireland, has expanded its laboratory offering in molecular diagnostic testing and brings expanded testing platforms.